- Scrip Originals
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Mabion S.A.
Clearance by UK regulator allows trial to restart, with pivotal US trial hoped to follow suit to keep AstraZeneca and Oxford's candidate on track for a potential late 2020 readout. Plus, new results with Sinovac's vaccine in the elderly and progress with antibodies.